Navigation Links
Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
Date:3/31/2008

Results of ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) involving 25,620 patients presented today at the 57th Annual Scientific Session of the American College of Cardiology

and published online in the New England Journal of Medicine

CHICAGO, March 31 /PRNewswire/ -- The results of the landmark ONTARGET(TM) trial have demonstrated that MICARDIS(R) (telmisartan), a second-generation angiotensin II receptor blocker (ARB), is equally effective as the current standard, ramipril, in reducing the risk of cardiovascular death, myocardial infarction, stroke and hospitalization for congestive heart failure in a broad cross-section of high-risk cardiovascular patients with normal blood pressure or controlled high blood pressure, and resulted in fewer discontinuations.(1) These cardiovascular events occurred in 1,423 patients (16.7 percent) receiving telmisartan versus 1,412 patients (16.5 percent) receiving ramipril.(1) The relative risk (ratio of the probability of the event occurring in the telmisartan group versus the ramipril group) was 1.01, with a 95 percent CI of 0.94 - 1.09.

Telmisartan is now the only ARB to have demonstrated cardio and vascular risk reduction benefits beyond lowering blood pressure in this high-risk population;(1) these benefits may be attributed to the specific pharmacological properties and mode of action of the drug. Previously, in 2000, the HOPE trial showed that the cardiovascular risk for patients treated with the angiotensin-converting enzyme (ACE) inhibitor ramipril was reduced by approximately 20 percent compared with placebo.(2) This meant that every fifth serious cardiovascular event in a high risk group of patients was prevented.(2)

"The ONTARGET trial shows that telmisartan is a well-tolerated treatment in high-risk cardiovascular patients that is as effective as ramipril in preventing heart attacks, stroke and hospitalizations for heart failure and dea
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

8

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
2. Viatronix V3D-Colon Utilized in Another Landmark Study
3. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
4. Hospital Launches Landmark Emergency Medicine Project
5. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
6. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013  Caradigm ... 4.0, a solution designed to help healthcare ... and data while supporting their compliance with ... Provisioning represents a milestone in the delivery ... analytics capabilities for health systems. ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... has recently added DrugPatentWatch to its ... http://www.bharatbook.com/drugpatentwatch-tour.pdf )      (Logo: ... comprehensive information on pharmaceutical, drug patents ... supports the critical business functions of ...
(Date:6/19/2013)... DST Health Solutions, LLC (DSTHS), a leading ... integrated delivery systems, and health care providers, has announced ... (MDMS) has jumped significantly. A customizable ... of medical prescription drug claims, MDMS allows ... drug claims processes. As specialty drug demand grows due ...
Breaking Medicine Technology:Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3Drug Patent Watch 2Drug Patent Watch 3Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3
(Date:6/19/2013)... June 19, 2013 The benefits, ... the sauna but the overall experience for the majority ... positive health-wise. , Mr Mouw, whose Virgina-based company enjoys ... Society’s statement by saying that the type of sauna ... a number of counterfeit imitations which frankly, can be ...
(Date:6/19/2013)... Daily Gossip issued a press release informing people that ... published on their website at the end of June. Reporters ... about the information they will find on the website. , ... Gossip, the article is a review of the newly published ... during the vast research he has performed that it is ...
(Date:6/19/2013)... 2013 Researchers from the Icahn ... new studies at ENDO 2013, The Endocrine Society’s ... in San Francisco.     , Mount Sinai researchers showed new ... of prostastic acid phosphatase (PAP) in Prostate Cancer (PCa) ... thyroid gland; revealed the prevalence of primary aldosteronism (PA) ...
(Date:6/19/2013)... HASCO Medical, Inc. (OTCBB: HASC), ... purchase privately held Auto Mobility Sales, Inc. of ... vehicle sales, service and rentals in southeastern Florida. ... and expands HASCO's strategy of becoming a leading ... The acquisition is subject to customary closing conditions, ...
(Date:6/19/2013)... Nashville, TN (PRWEB) June 19, 2013 ... the appointment of Dr. John Baxter to Vice President, ... currently serves as Director, Mental Health Services for CCA. ... "It is an honor and great privilege to lead ... offers the unique opportunity to serve society and our ...
Breaking Medicine News(10 mins):Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 3Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 4Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 5Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 6Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 7Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:CCA Names Dr. John Baxter Vice President, Health Services 2
... Children with eczema, a chronic skin condition that often begins ... food allergies. The number of children with eczema is ... new study soon to be published in The Journal ... eczema. Researchers found that dog ownership among children with ...
... breast cancer that also have mutations in the BRCA gene ... those with the same disease without the deleterious genetic mutation, ... Cancer Center. The findings may offer a direction for ... negative breast cancer patients, as well as highlight the unique ...
... HealthDay Reporter , WEDNESDAY, Sept. 29 (HealthDay ... effective in relieving knee pain from osteoarthritis, researchers are ... has halted a phase 3 trial of the drug ... replacements. Lead researcher Dr. Nancy E. Lane, director ...
... a three-year, $200,000 grant to Claudio Soto, Ph.D., professor ... Center at Houston (UTHealth), to pursue a procedure that ... of this project is to develop an efficient and ... can tell people they are in the process to ...
... Melvin and Bren Simon Cancer Center have published the ... brain tissue can occur in breast cancer patients undergoing ... to as "chemobrain," have been known for years. ... brain imaging to study women with breast cancer before ...
... September 28, 2010 -- The Accreditation Council for ... approved a set of requirements that are a ... professionalism, transitions in care, and resident well-being. Included ... nation,s 111,000 residents training in ACGME accredited teaching ...
Cached Medicine News:Health News:Dog ownership is associated with reduced eczema in children with dog allergies 2Health News:Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence 2Health News:Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence 3Health News:Novel Drug Eases Osteoarthritis Knee Pain 2Health News:IU researchers: Chemotherapy alters brain tissue in breast cancer patients 2Health News:ACGME board approves final duty hour and supervision standards for resident education 2Health News:ACGME board approves final duty hour and supervision standards for resident education 3
Intended for the quantitative determination of magnesium in serum or plasma. Reaction: Endpoint. Wavelength: 520 nm. Linearity: 6.0 mg/dL (2.5 mmol/L)....
For the quantitative determination of Magnesium in serum. Linearity: 4.0 mEq/L. Working Reagent prepared by simple 1:10 dilution....
For the quantitative determination of total glucose in serum....
Glucose reagent is used for the quantitative determination of glucose in human serum....
Medicine Products: